Aptar Reports First Quarter 2023 Results
First Quarter 2023 Highlights: • Reported sales grew 2% and core sales increased 4% driven by demand in Pharma and Beauty • Aptar Pharma reported sales growth of 4% and core sales growth of 7% • Aptar Beauty reported sales growth of 6% and core sales growth of 9% • Reported earnings per share decreased 12% to $0.82, due to restructuring charges • Operating cash flow was $98 million, up from $92 million in 2022